Should You Ride The Buoyant UK Economy With Tesco PLC, MJ GLEESON PLC ORD 2P And A FTSE 250 Tracker?

Why Tesco PLC (LON:TSCO), MJ GLEESON PLC ORD 2P (LON:GLE) and a FTSE 250 tracker (INDEXFTSE: MCX) could outperform the FTSE 100.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Data from the Office for National Statistics (ONS) on Wednesday is set to show that UK growth since the recession has been stronger than previously thought, the Sunday Times reported at the weekend.

And with the ONS having also recently reported that real wages increased at the fastest pace in more than a decade in the three months to July, continuing recovery bodes well for companies with a high level of exposure to the UK economy.

As such, Tesco (LSE: TSCO), MJ Gleeson (LSE: GLE) and a FTSE 250 tracker could all deliver strong returns for investors.

Tesco

Tesco generated 70% of its revenue from the UK last year. In absolute terms, the £44bn that passed through its UK tills was more than that of Sainsbury’s (£24bn) and Morrisons (£17bn) combined.

Tesco’s UK focus is set to grow as it looks to strengthen its balance sheet by selling off international assets. The company has already agreed a sale of its South Korean business for £4bn, and has reportedly been in talks to dispose of its Polish, Hungarian, Czech and Slovakian operations, which could raise a further £3bn.

The cash raised from international asset sales should give Tesco boss “Drastic Dave” Lewis more freedom and firepower to be more radical in turning around the UK business. With Tesco’s shares trading close to their 52-week low of 165p — 34% off their 251p spring high — earnings declines expected to bottom out this year, and an improving UK economy, now looks to be a good time to buy.

MJ Gleeson

Small-cap housebuilder MJ Gleeson, which released its annual results this morning, has a market value of £250m at a share price of 467p.

If you think the big housebuilders did well last year, take at a look at Gleeson’s numbers: revenue was up 44%, normalised earnings per share soared 99%, and the Board hiked the dividend by 67%.

Gleeson has a two-pronged strategy of building low cost homes in the north, and buying land, adding value and selling it on in the south. As a smaller company, Gleeson has scope for greater growth than larger peers, which should help it to outperform with the tailwinds of rising real incomes and the extension of the government’s Help to Buy scheme to 2020.

On a trailing price-to-earnings ratio of 14, with excellent prospects, Gleeson looks an attractive investment.

FTSE 250 tracker

Tesco’s turnaround story and Gleeson’s small size may not suit risk-averse investors. Indeed, they should form part of a well-diversified portfolio. For one-stop diversification and exposure to the UK economic recovery, a FTSE 250 tracker is an excellent option.

The FTSE 250 consists of the UK’s next largest 250 companies after the FTSE 100. While the top index is packed with global giants, such as Shell, HSBC and GlaxoSmithKline, the FTSE 250 has considerably more exposure to the UK. Also, while the top five companies of the FTSE 100 make up 25% of the index, the FTSE 250 is markedly less top-heavy in its weightings. Familiar names at the top of the FTSE 250, such as Rightmove, Provident Financial and Auto Trader, each account for barely more than 1% of the FTSE 250.

There are plenty of FTSE 250 tracker funds around to choose from, including the popular stock-market exchange traded fund HSBC FTSE 250 Index.

G A Chester has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »